T Eden

Author PubWeight™ 32.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Ifosfamide in paediatric oncology: tried but not tested? Lancet 1990 2.65
2 Childhood acute lymphoblastic leukemia and infections in the first year of life: a report from the United Kingdom Childhood Cancer Study. Am J Epidemiol 2006 2.02
3 p53 germline mutations in Li-Fraumeni syndrome. Lancet 1991 1.58
4 Guidelines for assistance to terminally ill children with cancer: a report of the SIOP Working Committee on psychosocial issues in pediatric oncology. Med Pediatr Oncol 1999 1.56
5 Determinants of symptom interval in childhood cancer. Arch Dis Child 1993 1.43
6 SIOP Working Committee on Psychosocial issues in pediatric oncology: guidelines for care of long-term survivors. Med Pediatr Oncol 1996 1.42
7 Pharmaceutical donations to eastern Europe. BMJ 1995 1.40
8 Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001. Leukemia 2009 1.40
9 The success of paediatric oncological research. Hosp Med 2001 1.39
10 Clonal spread among Swedish children of a Staphylococcus aureus strain resistant to fusidic acid. Scand J Infect Dis 2002 1.19
11 Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia 2000 1.08
12 Rates of inclusion of teenagers and young adults in England into National Cancer Research Network clinical trials: report from the National Cancer Research Institute (NCRI) Teenage and Young Adult Clinical Studies Development Group. Br J Cancer 2008 1.04
13 Understanding refusal and abandonment in the treatment of childhood cancer. Indian Pediatr 2010 1.04
14 The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29--30, 2005. Leukemia 2005 0.95
15 SIOP Working Committee on psychosocial issues in pediatric oncology: guidelines for communication of the diagnosis. Med Pediatr Oncol 1997 0.90
16 Guidelines for a therapeutic alliance between families and staff: a report of the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology. Med Pediatr Oncol 1998 0.90
17 Late relapsing childhood lymphoblastic leukemia. Blood 1998 0.89
18 Guidelines for the recognition, prevention, and remediation of burnout in health care professionals participating in the care of children with cancer: report of the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology. Med Pediatr Oncol 2000 0.89
19 The Eighth International Childhood Acute Lymphoblastic Leukemia Workshop ('Ponte di legno meeting') report: Vienna, Austria, April 27-28, 2005. Leukemia 2006 0.86
20 Guidelines for assistance to siblings of children with cancer: report of the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology. Med Pediatr Oncol 1999 0.86
21 Is growth hormone treatment beneficial or harmful in Costello syndrome? J Med Genet 2003 0.86
22 Neuroblastoma with intracranial involvement: an ENSG Study. Med Pediatr Oncol 1992 0.84
23 Investigation and management of Clostridium difficile colonisation in a paediatric oncology unit. Arch Dis Child 1995 0.84
24 "Noonan's syndrome and acute lymphoblastic leukaemia". Med Pediatr Oncol 1994 0.79
25 Increased frequency of Fanconi anemia group C genetic variants in children with sporadic acute myeloid leukemia. Blood 1998 0.78
26 Parvovirus B19 as a cause of chronic anemia in rhabdomyosarcoma. Cancer 1993 0.78
27 An odyssey in search of a cure: the evolution of treatment of childhood acute lymphoblastic leukemia in the United Kingdom. Indian J Pediatr 1994 0.78
28 Is communication guidance mistaken? Qualitative study of parent-oncologist communication in childhood cancer. Br J Cancer 2013 0.77
29 HLA-DPβ1 Asp84-Lys69 antigen-binding signature predicts event-free survival in childhood B-cell precursor acute lymphoblastic leukaemia: results from the MRC UKALL XI childhood ALL trial. Blood Cancer J 2012 0.75
30 Effects of Alcohol. Prov Med J Retrosp Med Sci 1844 0.75
31 Induction toxicity in childhood acute lymphoblastic leukemia: a comparison of two schedules of daunorubicin administration. Med Pediatr Oncol 1995 0.75
32 An audit of the activities of the paediatric oncology unit in Edinburgh, 1982-1991. Scott Med J 1993 0.75
33 Who can decide what is in a child's best interest? A problem-solving approach. Med Pediatr Oncol 2001 0.75
34 Measurements of GnE/GnM from the 2H(e-->,en-->)1H Reaction to Q2=1.45 (GeV/c)2. Phys Rev Lett 2003 0.75
35 Statement by members of the Ponte di Legno group on the right of children with leukemia to have full access to essential treatment for acute lymphoblastic leukemia. Ann Oncol 2005 0.75
36 Measurement of the charged pion electromagnetic form factor. Phys Rev Lett 2001 0.75
37 The treatment of Pseudomonas aeruginosa meningitis--old regime or newer drugs? Scand J Infect Dis 1993 0.75
38 [Non-conventional therapies in childhood cancer: guidelines for distinguishing non-harmful from harmful therapies: a report of the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology]. Klin Padiatr 2004 0.75
39 ["Picnic", a loony tale for all ages]. Soins Gerontol 2002 0.75
40 Measurement of the electric form factor of the neutron through d-->(e-->,e(')n)p at Q2 = 0.5 (GeV/c)(2). Phys Rev Lett 2001 0.75